Grantchester’s crimefighting duo tackle a knotty case. Plus, Channel 4 special Not Welcome: The Battle to Stop the Boats. Here’s what to watch this evening 9pm, ITV1 “One spread in Woman’s Own and he thinks he’s David Bailey …” The suspicious death of a self-regarding fashion photographer threatens to derail the grand opening of Cathy Keating and Mrs Chapman’s new boutique in sleepy Grantchester. ...
Grantchester’s crimefighting duo tackle a knotty case. Plus, Channel 4 special Not Welcome: The Battle to Stop the Boats. Here’s what to watch this evening 9pm, ITV1 “One spread in Woman’s Own and he thinks he’s David Bailey …” The suspicious death of a self-regarding fashion photographer threatens to derail the grand opening of Cathy Keating and Mrs Chapman’s new boutique in sleepy Grantchester. Thankfully, Rev Alphy and Cathy’s copper husband Geordie are on hand to tackle the knotty case, even if DI Keating seems equally determined to dig further into his holy friend’s family history. Might this cause some friction for the 1960s crimefighting duo? Graeme Virtue Continue reading...
Japan’s insurance industry is reeling from a raft of scandals that have exposed companies’ lax supervision of its employees, undermining trust in the sector at a time when the government is trying to drive more investment by individuals. Dai-ichi Life Holdings Inc. became the latest firm to reveal misconduct, joining Japan’s three other biggest life insurers including Sumitomo Life Insurance Co. i...
Japan’s insurance industry is reeling from a raft of scandals that have exposed companies’ lax supervision of its employees, undermining trust in the sector at a time when the government is trying to drive more investment by individuals. Dai-ichi Life Holdings Inc. became the latest firm to reveal misconduct, joining Japan’s three other biggest life insurers including Sumitomo Life Insurance Co. in saying that employees, seconded to financial firms selling their insurance, mishandled data. Before August 2024, 64 seconded employees from Dai-ichi Life and units obtained more than 1,000 pieces of data without approval, the insurer said in a statement. Prudential Financial Inc., meanwhile, suspended sales of new life insurance in Japan for 90 days earlier this month after disclosing that its employees conducted improper sales practices. Japanese insurers have been enmeshed in scandals in the past including price rigging and improper sales practices , but the latest troubles come at an especially sensitive time for financial firms. Policymakers are trying to get households to shift more to investing from saving as the population ages. Japan’s Financial Services Agency is planning to set up a division to oversee the insurance and asset management industries, underscoring policymakers’ focus on insurers. “If scandals of this magnitude continue to occur, distrust toward the industry itself could affect insurance sales,” said Hajime Ota, a professor at Doshisha University who researches business administration. Japanese insurers’ stocks have underperformed the broad market despite interest rate increases that tend to be a tailwind for their operations. In the past year, as the Topix benchmark jumped 42%, its insurance index gained 32%. The gauge for Japanese banks shot up 76% during the period. Experts say that the misconduct is fueled by huge sales forces fighting for business from a shrinking population. The total outstanding balance of individual life insurance and annuit...
Ida Akerblom/iStock via Getty Images The following segment was excerpted from the Baron Opportunity Fund Q4 2025 Shareholder Letter. Top contributors to performance for the quarter Contribution to Return (%) Space Exploration Technologies Corp. 4.42 X.AI Holdings Corp. 1.48 Eli Lilly & Company 1.05 Exact Sciences Corporation 0.90 Broadcom Inc. 0.45 Click to enlarge Space Exploration Technologies C...
Ida Akerblom/iStock via Getty Images The following segment was excerpted from the Baron Opportunity Fund Q4 2025 Shareholder Letter. Top contributors to performance for the quarter Contribution to Return (%) Space Exploration Technologies Corp. 4.42 X.AI Holdings Corp. 1.48 Eli Lilly & Company 1.05 Exact Sciences Corporation 0.90 Broadcom Inc. 0.45 Click to enlarge Space Exploration Technologies Corp. ( SPACE ) is a high-profile private company founded by Elon Musk. The company’s primary focus is on developing and launching advanced rockets, satellites, and spacecrafts, with the ambitious long-term goal of making life multi-planetary. SpaceX is generating significant value with the rapid expansion of its Starlink broadband service. The company is successfully deploying a vast constellation of Starlink satellites in Earth’s orbit, reporting substantial growth in active users, and regularly deploying new and more efficient hardware technology. Furthermore, SpaceX has established itself as a leading launch provider by offering highly reliable and cost-effective launches, leveraging the company’s reusable launch technology. SpaceX capabilities extend to strategic services such as human spaceflight missions. Moreover, SpaceX is making tremendous progress on its newest rocket, Starship, which is the largest, most powerful rocket ever flown. This next-generation vehicle represents a significant leap forward in reusability and space exploration capabilities. We value SpaceX using prices of recent financing transactions. X.AI Holdings Corp. ( XAI ) was formed in early 2025 through the merger of X (formerly Twitter) and xAI, an AI company founded by Elon Musk in March 2023 with the mission to "understand the true nature of the universe." This strategic union paired xAI's large language models with X's real-time data and worldwide distribution, speeding Grok's development while providing X with transformative AI tools for search, personalization, and user engagement. Shortly a...
NETSTREIT ( NTST ) priced a public offering of 10.98M shares at a public offering price of $19.00 per share in connection with the forward sale agreements. The underwriters have a 30-day option to purchase up to an additional 1.65M shares. Gross proceeds are expected to be over $208M. The offering is expected to close on February 13, 2026. The forward purchasers or affiliates will borrow and sell ...
NETSTREIT ( NTST ) priced a public offering of 10.98M shares at a public offering price of $19.00 per share in connection with the forward sale agreements. The underwriters have a 30-day option to purchase up to an additional 1.65M shares. Gross proceeds are expected to be over $208M. The offering is expected to close on February 13, 2026. The forward purchasers or affiliates will borrow and sell the shares to underwriters, with NETSTREIT settling later by delivering shares for cash at a forward price. More on NETSTREIT Netstreit: High-Quality REIT With Secure Yield And Compelling Growth (Upgrade) NETSTREIT Corp. (NTST) Q4 2025 Earnings Call Transcript NETSTREIT Corp. 2025 Q4 - Results - Earnings Call Presentation NETSTREIT launches public offering of common stock Netstreit signals AFFO per share growth target of 5% for 2026 while accelerating portfolio diversification
Anheuser-Busch InBev offset weaker volumes in Europe and North America with growth in other regions and stronger sales of premium products. Overall volumes at the world’s largest brewer declined 1.5% in the fourth quarter, according to a statement Thursday, less than analysts expected. The more upbeat update comes just a day after rival Heineken NV surprised the market by announcing plans to cut u...
Anheuser-Busch InBev offset weaker volumes in Europe and North America with growth in other regions and stronger sales of premium products. Overall volumes at the world’s largest brewer declined 1.5% in the fourth quarter, according to a statement Thursday, less than analysts expected. The more upbeat update comes just a day after rival Heineken NV surprised the market by announcing plans to cut up to 6,000 jobs — about 7% of its workforce — as it copes with an industrywide slump in beer demand. Read More: Heineken Cuts 7% of Staff as Beer Slump Weighs on Brewer Consumers worldwide are pulling back on their drinking following concerns over affordability and the negative health impacts of consuming alcohol. Peers Heineken, whose Chief Executive Officer Dolf van den Brink is on the way out, and Carlsberg A/S both cited uncertainty as the one of the main reasons for their weaker forecasts this year.
Igor Suka/E+ via Getty Images Dear Baron Opportunity Fund Shareholder, During the fourth quarter, Baron Opportunity Fund® (the Fund) posted a return of 4.63% (Institutional Shares), outperforming the Russell 3000 Growth Index (the Benchmark), which gained 1.14%, and the S&P 500 Index, which advanced 2.66%. For the full year 2025, the Fund appreciated 19.73%, beating the Benchmark, which rose 18.15...
Igor Suka/E+ via Getty Images Dear Baron Opportunity Fund Shareholder, During the fourth quarter, Baron Opportunity Fund® (the Fund) posted a return of 4.63% (Institutional Shares), outperforming the Russell 3000 Growth Index (the Benchmark), which gained 1.14%, and the S&P 500 Index, which advanced 2.66%. For the full year 2025, the Fund appreciated 19.73%, beating the Benchmark, which rose 18.15%, and the S&P 500 Index, which gained 17.88%. Annualized performance (%) for period ended December 31, 2025† Fund RetailShares 1,2 Fund Institutional Shares 1,2,3 Russell 3000 Growth Index 1 S&P 500 Index 1 QTD 4 4.56 4.63 1.14 2.66 1 Year 19.43 19.73 18.15 17.88 3 Years 35.69 36.05 30.25 23.01 5 Years 9.80 10.08 14.59 14.42 10 Years 19.83 20.15 17.59 14.82 15 Years 15.70 16.01 16.14 14.06 Since Inception(2/29/2000) 10.42 10.60 8.07 8.42 Click to enlarge Performance listed in the above table is net of annual operating expenses. Annual expense ratio for the Retail Shares and Institutional Shares as of January 28, 2025 was 1.31% and 1.05%, respectively The performance data quoted represents past performance. Past performance is no guarantee of future results. The investment return and principal value of an investment will fluctuate; an investor’s shares, when redeemed, may be worth more or less than their original cost. The Adviser may waive or reimburse certain Fund expenses pursuant to a contract expiring on August 29, 2036, unless renewed for another 11-year term and the Fund’s transfer agency expenses may be reduced by expense offsets from an unaffiliated transfer agent, without which performance would have been lower. Current performance may be lower or higher than the performance data quoted. For performance information current to the most recent month end, visit BaronCapitalGroup.com or call 1-800-99-BARON. Click to enlarge Review & Outlook Market Backdrop The fourth quarter of 2025 provided a steady finish to an otherwise turbulent year, with moderate gains across mo...
(RTTNews) - SMC Corp. (SMECF, SMCAY, 6273.T), a manufacturer, processor, and seller of automatic control equipment, on Thursday reported its net income increased despite lower sales in the nine months ended March 31.
(RTTNews) - SMC Corp. (SMECF, SMCAY, 6273.T), a manufacturer, processor, and seller of automatic control equipment, on Thursday reported its net income increased despite lower sales in the nine months ended March 31.
(RTTNews) - PearlAbyss Corp. (263750.KQ) reported a fourth quarter loss from continuing operation before corporate income tax of 2.0 billion won compared to profit of 57.0 billion won, prior year. Net loss to shareholders of the parent company was 14.4 billion won compared to pro
(RTTNews) - PearlAbyss Corp. (263750.KQ) reported a fourth quarter loss from continuing operation before corporate income tax of 2.0 billion won compared to profit of 57.0 billion won, prior year. Net loss to shareholders of the parent company was 14.4 billion won compared to pro
"Things are improving but the nitazenes that people are testing for will vary from lab to lab, and not every laboratory will be able to keep up to date with the newest nitazenes that are on the market," Lawson said.
"Things are improving but the nitazenes that people are testing for will vary from lab to lab, and not every laboratory will be able to keep up to date with the newest nitazenes that are on the market," Lawson said.